This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Obama Win Exposes Medical Stocks to QE Fatigue

Forecast 1-Year Return: Stocks with a red number are projected to decline by that percentage over the next 12 months. Stocks with a black number are projected to move higher by that percentage over the next 12 months.

Value Level: The price at which to enter a GTC Limit Order to buy on weakness. The letters mean; W-Weekly, M-Monthly, Q-Quarterly, S-Semiannual and A- Annual.

Pivot: A level between a value level and risky level that should be a magnet during the timeframe noted.

Risky Level: The price at which to enter a GTC Limit Order to sell on strength.

Abbott Labs (ABT) ($64.52 vs $66.03 on Aug 8) still has a buy rating according to ValuEngine with the stock above its 200-day simple moving average at $62.89. My annual value level is $59.79 with a quarterly pivot at $63.28 and weekly risky level at $68.62.

Amgen (AMGN) ($85.34 vs $81.57 on Aug 8) still has a buy rating and is above its 200-day SMA at $75.08. My quarterly value level lags at $77.19 with a weekly pivot at $86.33 and monthly risky level at $88.72.

Bristol-Myers (BMY) ($32.62 vs $32.54 on Aug 8) still has a buy rating with the stock below its 200-day SMA at $33.42. My annual value level is $30.23 with a weekly pivot at $33.62 and monthly risky level at $35.67.

Express Scripts (ESRX) ($54.95 vs $56.02 on Aug 8) still has a buy rating with the stock below its 200-day SMA at $56.77. My semiannual value level is $44.43 with a semiannual pivot at $53.18 and quarterly risky level at $58.12.

Gilead Sciences (GILD) ($65.45 vs $57.55 on Aug 8) has been downgraded to hold from buy since Aug. 8 with the stock above its 200-day SMA at $54.34. My quarterly value level is $60.53 with a monthly risky level at $68.87.

Johnson & Johnson (JNJ) ($70.34 vs $68.29 on Aug 8) still has a buy rating according to ValuEngine and is above its 200-day SMA at $66.53. My quarterly value level is $68.76 with an annual pivot at $70.65 with my annual risky level at $75.79.

2 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,254.47 +97.62 0.57%
S&P 500 2,009.53 +7.96 0.40%
NASDAQ 4,589.5430 +27.3540 0.60%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs